0001209191-21-062546.txt : 20211102
0001209191-21-062546.hdr.sgml : 20211102
20211102201146
ACCESSION NUMBER: 0001209191-21-062546
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211025
FILED AS OF DATE: 20211102
DATE AS OF CHANGE: 20211102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clark Daniel Emmett
CENTRAL INDEX KEY: 0001874449
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39482
FILM NUMBER: 211373240
MAIL ADDRESS:
STREET 1: C/O SEMA4 HOLDINGS CORP
STREET 2: 333 LUDLOW STREET, NORTH TOWER, 8TH FL.
CITY: STAMFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sema4 Holdings Corp.
CENTRAL INDEX KEY: 0001818331
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000]
IRS NUMBER: 851966622
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LUDLOW STREET
STREET 2: NORTH TOWER, 8TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 617 780 8742
MAIL ADDRESS:
STREET 1: 333 LUDLOW STREET
STREET 2: NORTH TOWER, 8TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
FORMER COMPANY:
FORMER CONFORMED NAME: CM Life Sciences, Inc.
DATE OF NAME CHANGE: 20200715
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-10-25
0
0001818331
Sema4 Holdings Corp.
SMFR
0001874449
Clark Daniel Emmett
C/O SEMA4 HOLDINGS CORP.
333 LUDLOW ST, NORTH TOWER, 8TH FL.
STAMFORD
CT
06902
0
1
0
0
Secretary and General Counsel
Class A Common Stock
2021-10-25
4
M
0
3940
A
3940
D
Class A Common Stock
2021-10-25
4
S
0
1256
7.54
D
2684
D
Restricted Stock Unit
2021-10-25
4
M
0
3940
0.00
D
Class A Common Stock
3940
59079
D
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
6.25% vest in quarterly installments over the four-year period commencing on July 25, 2021 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
/s/ Daniel Clark, Attorney-in-Fact
2021-11-02